Abstract
The first vaccine against malaria — and the first against any parasitic disease in humans — has limited efficacy in children of 27% to 39%, but it’s still a useful tool in combatting a long-standing and dire disease, say experts. “The pattern of disease arising from malaria is still very
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have